Cervavac HPV Vaccine WHO Prequalification Milestone
Source:The Hindu ↗
આ શા માટે મહત્વનું છે
Highlights India's growing prominence as a global vaccine hub, leveraging indigenous R&D and manufacturing to expand affordable healthcare access worldwide.
સારાંશ
Serum Institute of India's Cervavac, an indigenous quadrivalent human papillomavirus (HPV) vaccine for cervical cancer prevention, has received WHO prequalification, boosting global accessibility and manufacturing recognition.
મુખ્ય મુદ્દા
- Serum Institute of India's Cervavac, India’s first indigenous quadrivalent human papillomavirus (HPV) vaccine, has received WHO prequalification.
- WHO prequalification allows the vaccine to be procured by international agencies like UNICEF and GAVI, expanding global access and affordability.
- The milestone marks a major step forward for India's biotechnology sector, indigenous vaccine manufacturing capabilities, and global public health efforts against cervical cancer.
મહત્વપૂર્ણ શબ્દો
Cervavac
India's first indigenously developed quadrivalent human papillomavirus (qHPV) vaccine, produced by the Serum Institute of India, designed to prevent cervical and other HPV-related cancers.
UPSC context
Important for GS Paper II (Health, Government Policies) and GS Paper III (Indigenous R&D, Biotechnology), testing indigenous vaccine development and public health measures.
World Health Organization (WHO) prequalification
A specialized international agency of the United Nations responsible for international public health, which prequalifies medical products to ensure they meet global standards of quality, safety, and efficacy.
UPSC context
Relevant for GS Paper II (International Organizations) and global governance in health, assessing international standards and multilateral procurement mechanisms.
Serum Institute of India
The world's largest vaccine manufacturer by volume, based in Pune, India, known for producing affordable life-saving biologicals and vaccines globally.
UPSC context
Relevant for GS Paper III (Industrial Growth, Biotechnology, and Pharmaceutical Sector), assessing India's manufacturing capabilities and its role as the 'Pharmacy of the World.'
પ્રિલિમ્સ ટ્રેપ
WHO prequalification allows the vaccine to be manufactured and funded directly by international agencies like UNICEF.
Aspirants often assume WHO prequalification means the vaccine is manufactured by WHO or funded directly by it; in reality, it is a quality-assurance assessment enabling UN agencies to procure it.
સંલગ્ન સ્થિર ખ્યાલો
What is WHO Vaccine Prequalification and why is it significant for global health?
- Quality Assurance: Quality Assurance ensures vaccines supplied by UN agencies meet international standards of safety, efficacy, and quality.
- Global Procurement: Global Procurement enables agencies like UNICEF and GAVI to buy vaccines for low- and middle-income countries.
- Regulatory Shortcut: Regulatory Shortcut acts as a trusted regulatory stamp for national authorities in developing nations with limited capacity.
આંતર-વિષય પેટર્ન
Indigenous Biotech + Global Health Diplomacy
Indigenous vaccine manufacturing achievements under Mission COVID Suraksha and DBT bridge directly into global health diplomacy via UN and GAVI procurement channels.
WHO Prequalification + Pharmaceutical Export Markets
WHO prequalification acts as a quality stamp that bypasses domestic regulatory barriers in third-party nations, accelerating export-led growth in pharma.
Indigenous HPV vaccine WHO prequalification + GAVI procurement mechanism likely to be tested in a multi-statement prelims question.
સંલગ્ન PYQ · 1
સંલગ્ન PYQ · 1
- 2022MainsGS3
What is the basic principle behind vaccine development ? How do vaccines work? What approaches were adopted by the Indian vaccine manufacturers to produce COVID-19 vaccines ?
